Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Jomy George, PharmD, Maryalice Stetler-Stevenson, MD PhD, Mark Raffeld, MD, Constance M. Yuan, MD PhD, Joseph Ziegelbauer, PhD, Frank Maldarelli, MD PhD, William D. Figg, PharmD, Cody Peer, PhD, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2019) 134 (Supplement_1): 4096.

https://doi.org/10.1182/blood-2019-122070

Published: 2019

Journal Articles

Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib Resistance

Chingiz Underbayev, MD PhD, Inhye E Ahn, MD, Hailey Harris, Lauren T Vaughn, Mehdi Pirooznia, MD PhD, Liqiang Xi, MD, Mark Raffeld, MD, Sarah E. M. Herman, Adrian Wiestner, MD PhD

Blood (2019) 134 (Supplement_1): 1287.

https://doi.org/10.1182/blood-2019-127364

Published: 2019

Journal Articles

Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia Variant

Dai Chihara, MD PhD, Evgeny Arons, PhD, Maryalice Stetler-Stevenson, MD PhD, Constance M. Yuan, MD PhD, Hao-Wei Wang, MD PhD, Hong Zhou, Mark Raffeld, MD, Liqiang Xi, MD, Seth M. Steinberg, PhD, Julie Feurtado, RN, Lacey James-Echenique, CRNP, Wyndham Wilson, MD, Raul C. Braylan, MD, Katherine R. Calvo, MD PhD, Irina Maric, MD MSci, Alina Dulau-Florea, MD, Robert J. Kreitman, MD

Blood (2019) 134 (Supplement_1): 1536.

https://doi.org/10.1182/blood-2019-124515

Published: 2019

Journal Articles

Hodgkin Lymphoma Variant of Richter Transformation: Morphology, EBV Status, Clonality and Survival Analysis a Retrospective Study of 77 Patients

Wenbin Xao, MD PhD, Wayne Chen, MD PhD, Lynn Sorbara, PhD, Theresa Davies-Hill, Stefania Pittaluga, MD PhD, Mark Raffeld, MD, Elaine S Jaffe, MD

Blood (2015) 126 (23): 2637.

https://doi.org/10.1182/blood.V126.23.2637.2637

Published: 2015

Journal Articles

Series of Hairy Cell Leukemia Patients with Co-Existent Plasma Cell Disorders

Neha Korde, MD, Sham Mailankody, MD, Evgeny Arons, PhD, Raul C. Braylan, MD, Mark Raffeld, MD, Elizabeth Maestri, RN, Constance Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Ola Landgren, MD PhD, Irina Maric, MD, Robert J. Kreitman, MD

Blood (2014) 124 (21): 5647.

https://doi.org/10.1182/blood.V124.21.5647.5647

Published: 2014

Journal Articles

B-Cell Maturation Antigen Is a Promising Target for Genetically-Modified T-Cell Therapy of Multiple Myeloma

Robert O. Carpenter, Moses O. Evbuomwan, Stefania Pittaluga, Jeremy J. Rose, Mark Raffeld, MD, Shicheng Yang, Ronald E. Gress, Frances T. Hakim, MD, James N. Kochenderfer

Blood (2012) 120 (21): 937.

https://doi.org/10.1182/blood.V120.21.937.937

Published: 2012

Journal Articles

Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients

Blood (2012) 120 (21): 732.

https://doi.org/10.1182/blood.V120.21.732.732

Published: 2012

Journal Articles

Resolution of Hairy Cell Leukemia Minimal Residual Disease by Both BRAF and Clone-Specific Real-Time Quantitative PCR (RQ-PCR) After Treatment with Moxetumomab Pasudotox.

Robert J. Kreitman, MD, Evgeny Arons, PhD, Sapolsky Jeffrey, Laura Roth, Hong Zhou, BS, Maryalice Stetler-Stevenson, MD, PhD, Wyndham H. Wilson, MD, PhD, Mark Raffeld, MD, David J. P. FitzGerald, PhD, Ji Fei, PhD, Ramy Ibrahim, MD, Ira Pastan, MD

Blood (2012) 120 (21): 2896.

https://doi.org/10.1182/blood.V120.21.2896.2896

Published: 2012

Journal Articles

A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies and Post-Transplant Relapse

Nirali N Shah, MD, David Loeb, MD, PhD, Hahn Khuu, MD, David Stroncek, MD, Mark Raffeld, MD, Cindy Delbrook, RN, Kelly Richards, RN, Kristin Baird, MD, Jason Levine, MD, Susan F. Leitman, MD, Crystal L Mackall, MD, Terry J Fry, MD, Alan S Wayne, MD

Blood (2011) 118 (21): 3055.

https://doi.org/10.1182/blood.V118.21.3055.3055

Published: 2011

Journal Articles

Presence and Absence of the BRAF V600E Mutation in Hairy Cell Leukemia and Its Variants

Robert J. Kreitman, MD, Liqiang Xi, MD, Winnifred Navarro, BS, Maryalice Stetler-Stevenson, MD, PhD, Evgeny Arons, PhD, Mark Raffeld, MD

Blood (2011) 118 (21): 931.

https://doi.org/10.1182/blood.V118.21.931.931

Published: 2011

Journal Articles

Molecular Characterization and Clinical Correlations of MEK1/2 Inhibition (AZD6244) in Relapse or Refractory Multiple Myeloma: Analysis From a Phase II Study

Adriana Zingone, MD, PhD, Neha Korde, MD, Jinqiu Chen, PhD, Liqiang Xi, MD, Mark Raffeld, MD, Beata Holkova, MD, Maciej Kmieciak, PhD, Daniel Sullivan, MD, Austin Doyle, MD, Irina Maric, MD, Katherine Calvo, MD, PhD, Mary Ann Yancey, RN, Marcia Mulquin, RN, Christina Annunziata, MD, PhD, Steven Grant, MD, Ola Landgren, MD, PhD

Blood (2011) 118 (21): 306.

https://doi.org/10.1182/blood.V118.21.306.306

Published: 2011

Journal Articles

Interim Results of Secondary Endpoints From a Randomized Trial of Cladribine with Early Vs Delayed Rituximab for Treatment of Early Hairy Cell Leukemia

Robert J Kreitman, MD, Wyndham H. Wilson, MD, PhD, Hong Zhou, BS, Mark Raffeld, MD, Maryalice Stetler-Stevenson, MD, PhD, Evgeny Arons, PhD

Blood (2011) 118 (21): 2856.

https://doi.org/10.1182/blood.V118.21.2856.2856

Published: 2011

Journal Articles

PI3K a Selective Inhibitor Induces Growth Inhibition In Mantle Cell Lymphoma

Yixin Zhou, Linhua Jin, PhD, Stefania Pittaluga, MD, PhD, Mark Raffeld, MD, PhD, Takashi Miida, MD, PhD, Yoko Tabe, MD, PhD

Blood (2010) 116 (21): 1812.

https://doi.org/10.1182/blood.V116.21.1812.1812

Published: 2010

Journal Articles

MDM2 Antagonist Nutlin-3 Enhances Bortezomib-Mediated Mitochondrial Apoptosis In TP53-Mutated Mantle Cell Lymphoma

Yoko Tabe, MD, PhD, Linhua Jin, PhD, Kensuke Kojima, MD, PhD, Yixin Zhou, Stefania Pittaluga, MD, PhD, Marina Konopleva, MD, PhD, Takashi Miida, MD, PhD, Mark Raffeld, MD, PhD

Blood (2010) 116 (21): 3920.

https://doi.org/10.1182/blood.V116.21.3920.3920

Published: 2010

Journal Articles

PTEN Regulates SYK-Directed AKT Activation in MCL.

Martina Rudelius, MD, Stefania Pittaluga, MD, PhD, Denise Sebasigari, Theresa Davies-Hill, Margit Klier, Leticia Quintanilla-Martinez, MD, Falko Fend, Prof, Yoko Tabe, Mark Raffeld, MD

Blood (2009) 114 (22): 2941.

https://doi.org/10.1182/blood.V114.22.2941.2941

Published: 2009

Journal Articles

Identification of Cyclin D1-Dependent Genes by Gene Expression Profiling in MCL Cell Lines and Primary Cases.

Margit Klier-Richter, PhD, Martin Irmler, PhD, Irina Bonzheim, PhD, Sabine Schaefer, Johannes Beckers, PhD, Falko Fend, Prof, Mark Raffeld, MD, Leticia Quintanilla-Martinez, MD

Blood (2009) 114 (22): 3936.

https://doi.org/10.1182/blood.V114.22.3936.3936

Published: 2009

Journal Articles

Identification of Genes Which Play a Crucial Role in C/EBPβ Downstream Signalling in ALK + ALCL Cell Lines.

Irina Bonzheim, PhD, Martin Irmler, PhD, Natasa Anastasov, PhD, Margit Klier-Richter, PhD, Sabine Schaefer, Johannes Beckers, PhD, Stefania Pittaluga, MD, Falko Fend, Prof, Mark Raffeld, MD, Leticia Quintanilla-Martinez, MD

Blood (2009) 114 (22): 1943.

https://doi.org/10.1182/blood.V114.22.1943.1943

Published: 2009

Journal Articles

Gene Expression Profiling Reveals a Crucial Role for C/EBPbeta in Proliferation Pathways of ALK + ALCL Cell Lines

Irina Bonzheim, PhD, Martin Irmler, PhD, Natasa Anastasov, PhD, Margit Klier, Johannes Beckers, PhD, Stefania Pittaluga, MD, Falko Fend, Mark Raffeld, MD, Leticia Quintanilla-Martinez, MD

Blood (2008) 112 (11): 2818.

https://doi.org/10.1182/blood.V112.11.2818.2818

Published: 2008

Journal Articles

Targeting CDK4 in Mantle Cell Lymphoma (MCL) Cell Lines by Specific Lentiviral shRNA Mediated Knockdown Has Profound Effects on Cell Growth and Cell Cycle but Minimal Effects on Apoptosis.

Margit Klier, Irina Bonzheim, PhD, Natasa Anastasov, PhD, Daniela Angermeier, Mark Raffeld, MD, Falko Fend, MD, Leticia Quintanilla-Martinez, MD

Blood (2008) 112 (11): 1767.

https://doi.org/10.1182/blood.V112.11.1767.1767

Published: 2008

Journal Articles

Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma.

Kamal Sharma, DO, John E. Janik, MD, Deirdre O’Mahony, MD, Donn Stewart, MD, Stefania Pittaluga, MD, Maryalice Stetler-Stevenson, MD, PhD, Elaine S. Jaffe, MD, Mark Raffeld, MD, Thomas A. Fleisher, MD, Cathryn C. Lee, NP, Nicole Urquhart, MD, Seth Steinberg, PhD, Thomas A. Waldmann, MD, John C. Morris, MD

Blood (2008) 112 (11): 2010.

https://doi.org/10.1182/blood.V112.11.2010.2010

Published: 2008

NARROW

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib Resistance

Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia Variant

Hodgkin Lymphoma Variant of Richter Transformation: Morphology, EBV Status, Clonality and Survival Analysis a Retrospective Study of 77 Patients

Series of Hairy Cell Leukemia Patients with Co-Existent Plasma Cell Disorders

B-Cell Maturation Antigen Is a Promising Target for Genetically-Modified T-Cell Therapy of Multiple Myeloma

Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients

Resolution of Hairy Cell Leukemia Minimal Residual Disease by Both BRAF and Clone-Specific Real-Time Quantitative PCR (RQ-PCR) After Treatment with Moxetumomab Pasudotox.

A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies and Post-Transplant Relapse

Presence and Absence of the BRAF V600E Mutation in Hairy Cell Leukemia and Its Variants

Molecular Characterization and Clinical Correlations of MEK1/2 Inhibition (AZD6244) in Relapse or Refractory Multiple Myeloma: Analysis From a Phase II Study

Interim Results of Secondary Endpoints From a Randomized Trial of Cladribine with Early Vs Delayed Rituximab for Treatment of Early Hairy Cell Leukemia

PI3K a Selective Inhibitor Induces Growth Inhibition In Mantle Cell Lymphoma

MDM2 Antagonist Nutlin-3 Enhances Bortezomib-Mediated Mitochondrial Apoptosis In TP53-Mutated Mantle Cell Lymphoma

PTEN Regulates SYK-Directed AKT Activation in MCL.

Identification of Cyclin D1-Dependent Genes by Gene Expression Profiling in MCL Cell Lines and Primary Cases.

Identification of Genes Which Play a Crucial Role in C/EBPβ Downstream Signalling in ALK + ALCL Cell Lines.

Gene Expression Profiling Reveals a Crucial Role for C/EBPbeta in Proliferation Pathways of ALK + ALCL Cell Lines

Targeting CDK4 in Mantle Cell Lymphoma (MCL) Cell Lines by Specific Lentiviral shRNA Mediated Knockdown Has Profound Effects on Cell Growth and Cell Cycle but Minimal Effects on Apoptosis.

Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only